| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4273164 | The Journal of Sexual Medicine | 2007 | 13 Pages |
Abstract
Short-term treatment demonstrated a higher incidence of treatment-emergent sexual dysfunction with escitalopram compared with duloxetine and placebo. After 12Â weeks, there were no statistically significant differences between drugs; however, MDD outcome (regardless of treatment) had a significant impact on improvement in global sexual functioning. Clayton A, Kornstein S, Prakash A, Mallinckrodt C, and Wohlreich M. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Anita MD, Susan MD, Apurva BA, Craig PhD, Madelaine MD,